Page results
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Information covering a range of conditions. Search by condition name or condition type (specialty).
-
Colleagues, past and present, came together to mark the tenth anniversary of University College Hospital at Westmoreland Street.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.
-
One of the FOIA Code of Practice requirements is for public authorities to publish more information about their performance in handling FOIA requests.
File results
-
FOI/2021/0457 - International staff
-
FOI/2021/0458 - Breathing filters used in mechanical ventilators for (COVID-19) patients
-
FOI/2021/0463 - Staff accommodation
-
FOI/2021/0466 - Patient wait of more than 52 weeks for elective treatment
-
FOI/2021/0467 - Celebration of Pride in 2020 and 2021
-
FOI/2021/0468 - Patient data management system
-
FOI/2021/0475 - Covid-19 deaths
-
FOI/2021/0485 - Patient transport policy
-
FOI/2021/0490 - Greener NHS National Programme
-
FOI/2021/0494 - Maternity patients not eligible for free healthcare